INSERM U1065, C3M, Université Côte d'Azur, Nice, France.
Degenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
FEBS J. 2020 May;287(9):1722-1736. doi: 10.1111/febs.15179. Epub 2020 Jan 8.
Cellular gatekeepers are essential to maintain order within a cell and anticipate signals of stress to promote survival. BCL2 associated X, apoptosis regulator (BAX) inhibitor-1 (BI-1), also named transmembrane BAX inhibitor motif containing-6, is a highly conserved endoplasmic reticulum (ER) transmembrane protein. Originally identified as an inhibitor of BAX-induced apoptosis, its pro-survival properties have been expanded to include functions targeted against ER stress, calcium imbalance, reactive oxygen species accumulation, and metabolic dysregulation. Nevertheless, the structural biology and biochemical mechanism of action of BI-1 are still under debate. BI-1 has been implicated in several diseases, including chronic liver disease, diabetes, ischemia/reperfusion injury, neurodegeneration, and cancer. While most studies have demonstrated a beneficial role for BI-1 in the ubiquitous maintenance of cellular homeostasis, its expression in cancer cells seems most often to contribute to tumorigenesis and metastasis. Here, we summarize what is known about BI-1 and encourage future studies on BI-1's contribution to cellular life and death decisions to advocate its potential as a target for drug development and other therapeutic strategies.
细胞门卫对于维持细胞内的秩序和感知应激信号以促进生存至关重要。BCL2 相关 X,凋亡调节因子(BAX)抑制剂-1(BI-1),也称为跨膜 BAX 抑制剂基序包含-6,是一种高度保守的内质网(ER)跨膜蛋白。BI-1 最初被鉴定为 BAX 诱导的细胞凋亡抑制剂,其生存促进特性已扩展到针对 ER 应激、钙失衡、活性氧积累和代谢失调的功能。然而,BI-1 的结构生物学和生化作用机制仍存在争议。BI-1 与几种疾病有关,包括慢性肝病、糖尿病、缺血/再灌注损伤、神经退行性变和癌症。虽然大多数研究表明 BI-1 在普遍维持细胞内稳态方面具有有益作用,但它在癌细胞中的表达似乎常常有助于肿瘤发生和转移。在这里,我们总结了关于 BI-1 的已知信息,并鼓励未来研究 BI-1 对细胞生死决策的贡献,以提倡其作为药物开发和其他治疗策略的潜在靶点。